Last reviewed · How we verify
NCT06998680
6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair
NA trial testing VitaGreen Capsule A+VitaGreen Tonic in Alopecia in 152 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | Vita Green Pharmaceutical (H.K.) Ltd. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 152 |
| Start date | 30 July 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 October 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- VitaGreen Capsule A+VitaGreen Tonic
- VitaGreen Capsule B+VitaGreen Tonic
- Capsule Placebo+VitaGreen Tonic
- Capsule Placebo+Tonic Placebo
Conditions studied
Sponsor
Vita Green Pharmaceutical (H.K.) Ltd.
Who can join
Adults 18 to 60, any sex, with Alopecia or Canities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This will be a 6-month randomized, double-blind, placebo-controlled trial. A total of 152 participants with hair loss, including some with gray hair, will be enrolled and randomly assigned to four groups. Each group will receive a combination of oral capsules and hair tonic, to be used as directed for 24 weeks. Participants will attend three in-person visits, during which assessments-including hair-related tests and photographs-will be conducted to evaluate hair count and density. Additionally, 10 participants with gray hair from each group will undergo extra assessments focused on changes in hair color. All relevant clinical data will be systematically collected and recorded for statistical analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06998680
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alopecia
Currently open trials in the same condition.
- NCT07422376 — Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variation · NA · recruiting
- NCT07107841 — Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) · NA · recruiting
- NCT05484973 — Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss · NA · recruiting
- NCT06215469 — Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) · NA · recruiting
- NCT06283316 — Systemic Treatments for Alopecia Areata Registry · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06998680 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vita Green Pharmaceutical (H.K.) Ltd.
- Last refreshed: 19 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06998680.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing